BLOOD PRODUCTS CLE

The Department of Veterans Affairs is conducting market research through a Sources‑Sought notice to assess industry capability and interest in providing a full spectrum of blood products and associated transfusion support services for the Louis Stokes Cleveland VA Medical Center (Cleveland, OH). Required items include leukoreduced red blood cells, apheresis platelets, plasma, cryoprecipitate, low‑titer O whole blood, specialty components, and related laboratory/immunohematology services such as antigen typing, molecular testing, antibody identification, rare‑donor procurement, HLA‑selected platelets, and STAT processing. All products must comply with FDA, AABB, and applicable blood‑banking regulations for collection, processing, testing, storage, and transport, and the contractor must be able to meet routine and emergency demand. Responses are voluntary, informational only, and will not be compensated or returned. Interested vendors must submit a point‑of‑contact, business information, socio‑economic status, relevant contract numbers (GSA, NAC, TAC, or SAC), capability statement or brochures, SAM UEI, delivery lead time, country of origin, OEM/distributor status (including OEM identification and an authorized distributor letter), and a letter from Olympus America, Inc. confirming compatibility. Submissions are due to Contracting Officer Rachelle J. Hamer (rachelle.hamer@va.gov) by 11 a.m. ET, Friday March 20, 2026. No set‑aside is anticipated, and a future competitive solicitation will be posted on SAM.gov.

Notice ID

943001dfe16049608a9355187131fb87

Solicitation Number

36C25026Q0391

NAICS Code

621991

Classification Code

6506